Publications by authors named "Alexander E Drilon"

Claim this Profile
D
Decision-making as discovery: Vetting clinical research in a leading precision oncology service.
Alberto Cambrosio, Jonah Campbell, Alexander E Drilon, Peter Keating, Jess B Polk

Sociol Health Illn· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organizing precision medicine: A case study of Memorial Sloan Kettering Cancer Center's engagement in/with genomics.
Jess B Polk, Jonah Campbell, Alexander E Drilon, Peter Keating, Alberto Cambrosio

Soc Sci Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectrum of Mutations and Gene Rearrangements in Ovarian Serous Carcinoma.
M Herman Chui, Jason C Chang, Yanming Zhang, Ahmet Zehir, Alison M Schram, Alexander E Drilon

JCO Precis Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of drug-induced liver injury in early-phase oncology clinical trials.
Sebastian P Mondaca, Dazhi Liu, Jessica R Flynn, Sandy Badson, Stefan Hamaway, Alexander E Drilon

Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements.
Jason C Chang, Lei Zhang, Alexander E Drilon, Ping Chi, Rita Alaggio

J Thorac Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.
Natasha Rekhtman, Maria C Pietanza, Matthew D Hellmann, Jarushka Naidoo, Arshi Arora, Alexander E Drilon

Clin Cancer Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired Resistance of EGFR-Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor: Emergence of a Third Mutation (C797S) in the EGFR Tyrosine Kinase Domain.
Helena A Yu, Shaozhou K Tian, Alexander E Drilon, Laetitia Borsu, Gregory J Riely

JAMA Oncol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis